Vasohibin, a novel regulator of angiogenesis, as a useful for molecular targeted therapy and gene therapy in gynecologic malignancies
| Project/Area Number |
21592143
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Jichi Medical University |
|---|
Principal Investigator |
SAGA Yasushi 自治医科大学, 医学部, 講師 (70360071)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 卵巣がん / 子宮体がん / 分子標的治療 / 遺伝子治療 / 腫瘍血管新生 / バソヒビン / アデノ随伴ウイルスベクター / 婦人性器癌 / バソヒビン1 / 婦人性器がん / 濃伝子治療 |
|---|
| Research Abstract |
We showed that vasohibin-1(VASH1), a novel regulator of angiogenesis discovered in this country, can control tumor growth through inhibition of angiogenesis in various gynecologic malignancies. Moreover, we established an adeno-associated virus vector which carries VASH1.These results suggest the possibility of molecular targeted therapy and gene therapy in gynecologic malignancies using VASH1.
|
Report
(4 results)
Research Products
(18 results)
